Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Apollo Endosurgery, Inc. (NASDAQ: APEN).

Full DD Report for APEN

You must become a subscriber to view this report.


Recent News from (NASDAQ: APEN)

Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients
Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy an...
Source: Business Wire
Date: May, 14 2018 05:00
Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures
Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty (“ESG&#...
Source: Business Wire
Date: May, 08 2018 16:01
Free Post Earnings Research Report: Edwards Lifesciences' Adjusted Sales Grew 9.3%; Adjusted EPS Surged 30%
Stock Monitor: Apollo Endosurgery Post Earnings Reporting LONDON, UK / ACCESSWIRE / May 08, 2018 / If you want access to our free earnings report on Edwards Lifesciences Corp. (NYSE: EW ), all you need to do is sign up now by clicking the following link www.active-investors.com/regi...
Source: ACCESSWIRE IA
Date: May, 08 2018 07:40
Apollo Endosurgery misses by $0.07, misses on revenue
Apollo Endosurgery (NASDAQ: APEN ): Q1 EPS of -$0.47 misses by $0.07 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 03 2018 16:18
Apollo Endosurgery, Inc. Reports First Quarter 2018 Results
Total Endo-bariatric Product Sales Increased 40% in the First Quarter Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal proce...
Source: Business Wire
Date: May, 03 2018 16:01
Apollo Endosurgery, Inc. to Report First Quarter Results on May 3, 2018
Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its financial results for the first quarter ended March 31, 2018 on Thursday, May 3, 2018,...
Source: Business Wire
Date: April, 26 2018 16:01
Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365(TM) - in the Kingdom of Saudi Arabia
Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365™ Managed Weight Loss System and has...
Source: Business Wire
Date: April, 23 2018 16:01
Premarket analyst action - healthcare
Celgene (NASDAQ: CELG ) resumed with Equal Weight rating and $93 (4% upside) price target at Morgan Stanley. More news on: Celgene Corporation, Corcept Therapeutics Incorporated, Endocyte, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 13 2018 08:06
Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurgery, The KEYW Holding, FARO Technologies, and Tilly's - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD), Summit Hotel Properties, ...
Source: GlobeNewswire
Date: March, 30 2018 07:50
Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study
Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the FDA has approved the termination of the LAP-BAND® Lower Body Mass Index (BMI) Post-approval study (&#...
Source: Business Wire
Date: March, 12 2018 18:10

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-186.386.546.545.9958,044
2018-05-176.386.546.545.9958,044

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-256,02510,91555.1993Short
2018-05-242,1527,19929.8930Cover
2018-05-232,1748,41425.8379Cover
2018-05-222,3985,95540.2687Short
2018-05-219,50911,66081.5523Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on APEN.


About Apollo Endosurgery, Inc. (NASDAQ: APEN)

Logo for Apollo Endosurgery, Inc. (NASDAQ: APEN)

Lpath, Inc., headquartered in San Diego, is the category leader in lipid based therapeutics, an emerging field of medical science whereby bioactive signaling lipids are targeted for treating important human diseases.

 

Contact Information

 

 

Current Management

  • Scott Pancoast / President, CEO
  • Gary Atkinson / Vice President, CFO, Principal Fin. Officer, Principal Acct. Officer
  • Roger Sabbadini / Vice President
  • Terry Trzcinka / IR

Current Share Structure

  • Market Cap: $109,434,056 - 05/11/2018
  • Issue and Outstanding: 17,509,449 - 04/30/2018

 


Recent Filings from (NASDAQ: APEN)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 06 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018

 

 


Daily Technical Chart for (NASDAQ: APEN)

Daily Technical Chart for (NASDAQ: APEN)


Stay tuned for daily updates and more on (NASDAQ: APEN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: APEN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in APEN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of APEN and does not buy, sell, or trade any shares of APEN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/